EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 253 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $2,136,645 | +342.2% | 290,700 | +523.2% | 0.00% | +300.0% |
Q1 2023 | $483,221 | -9.4% | 46,643 | +3.3% | 0.00% | 0.0% |
Q4 2022 | $533,139 | -46.6% | 45,143 | +96.4% | 0.00% | 0.0% |
Q4 2021 | $999,000 | -40.2% | 22,984 | -31.1% | 0.00% | 0.0% |
Q3 2021 | $1,671,000 | +11.5% | 33,380 | +40.4% | 0.00% | 0.0% |
Q2 2021 | $1,498,000 | -29.5% | 23,775 | +3.9% | 0.00% | -50.0% |
Q1 2021 | $2,125,000 | +42.8% | 22,872 | +37.7% | 0.00% | +100.0% |
Q4 2020 | $1,488,000 | -61.3% | 16,612 | -55.4% | 0.00% | -75.0% |
Q3 2020 | $3,846,000 | +33.9% | 37,218 | +2.5% | 0.00% | +33.3% |
Q2 2020 | $2,872,000 | +39.3% | 36,316 | +2.0% | 0.00% | 0.0% |
Q1 2020 | $2,061,000 | +122.1% | 35,616 | +107.0% | 0.00% | +200.0% |
Q4 2019 | $928,000 | +4.9% | 17,204 | +1.5% | 0.00% | 0.0% |
Q3 2019 | $885,000 | -12.7% | 16,942 | -19.3% | 0.00% | 0.0% |
Q2 2019 | $1,014,000 | -83.1% | 20,988 | -82.3% | 0.00% | -83.3% |
Q1 2019 | $5,997,000 | +1.6% | 118,714 | +19.2% | 0.01% | 0.0% |
Q4 2018 | $5,904,000 | -12.6% | 99,599 | -2.9% | 0.01% | 0.0% |
Q3 2018 | $6,754,000 | +27.8% | 102,608 | -2.0% | 0.01% | +20.0% |
Q2 2018 | $5,285,000 | -11.1% | 104,672 | -7.3% | 0.01% | -16.7% |
Q1 2018 | $5,942,000 | +82.3% | 112,858 | +60.9% | 0.01% | +100.0% |
Q4 2017 | $3,259,000 | +18.6% | 70,130 | +3.3% | 0.00% | +50.0% |
Q3 2017 | $2,747,000 | +19.1% | 67,913 | -0.4% | 0.00% | 0.0% |
Q2 2017 | $2,306,000 | +3.4% | 68,203 | -11.2% | 0.00% | 0.0% |
Q1 2017 | $2,230,000 | -11.5% | 76,780 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $2,521,000 | -40.3% | 76,780 | -49.5% | 0.00% | -50.0% |
Q3 2016 | $4,220,000 | +60.5% | 152,034 | +62.6% | 0.00% | +33.3% |
Q2 2016 | $2,629,000 | -49.6% | 93,487 | -34.9% | 0.00% | -50.0% |
Q1 2016 | $5,221,000 | +542.2% | 143,632 | +611.5% | 0.01% | +500.0% |
Q4 2015 | $813,000 | +52.2% | 20,186 | +7.7% | 0.00% | 0.0% |
Q3 2015 | $534,000 | -14.4% | 18,744 | -1.0% | 0.00% | 0.0% |
Q2 2015 | $624,000 | +7.0% | 18,932 | -6.6% | 0.00% | 0.0% |
Q1 2015 | $583,000 | -48.8% | 20,273 | -51.5% | 0.00% | 0.0% |
Q4 2014 | $1,139,000 | +32.9% | 41,837 | +4.0% | 0.00% | 0.0% |
Q3 2014 | $857,000 | +99.3% | 40,237 | +110.1% | 0.00% | 0.0% |
Q2 2014 | $430,000 | -84.9% | 19,148 | -83.0% | 0.00% | -66.7% |
Q1 2014 | $2,844,000 | – | 112,536 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 25,250 | $784,000 | 2.30% |
Global Alpha Capital Management Ltd. | 418,030 | $12,976,000 | 1.40% |
AIMZ Investment Advisors, LLC | 70,588 | $2,191,000 | 1.05% |
PALISADE CAPITAL MANAGEMENT, LP | 566,080 | $17,571,000 | 0.48% |
RICE HALL JAMES & ASSOCIATES, LLC | 261,533 | $8,118,000 | 0.39% |
EARNEST PARTNERS LLC | 1,844,621 | $57,257,000 | 0.38% |
SummerHaven Investment Management, LLC | 14,476 | $449,000 | 0.30% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,085,874 | $33,706,000 | 0.26% |
Ridgewood Investments LLC | 10,004 | $311,000 | 0.24% |
DUALITY ADVISERS, LP | 65,650 | $2,038,000 | 0.20% |